Phospholipid Analogs Against HIV-1 Infection and Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|18|1441-1451

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.18, 2003-07, pp. : 1441-1451

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonoxinol-9 offers no protection against HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cryptococcal disease and HIV infection

By Waters Laura   Nelson Mark  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2633-2644

Informa Healthcare

Access to resources Recommend Favorite

Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial

By Cai T.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 517-538

Taylor & Francis Ltd

Access to resources Recommend Favorite

New developments in the fight against HIV infection

By  

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Bacterial Toxins: Potential Weapons Against HIV Infection

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2909-2926

Bentham Science Publishers

Access to resources Recommend Favorite